1. D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats. (11th August 2017) Authors: Lindenbach, David; Das, Banibrata; Conti, Melissa M; Meadows, Samantha M; Dutta, Aloke K; Bishop, Christopher Journal: British journal of pharmacology Issue: Volume 174:Number 18(2017) Page Start: 3058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗